Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE ROLE OF BBB BREAKDOWN IN THE PATHOGENESIS OF PSYCHIATRIC DISORDERS

NCT01396850 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT01396850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01396850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE ROLE OF BBB BREAKDOWN IN THE PATHOGENESIS OF PSYCHIATRIC DISORDERS
Lead sponsor
Soroka University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis